5 terminated. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 5 |
| Phase 2 | 1 | Terminated 1 |
Follow Pt: new trials by email Literature Review of Pt trials Research Report on Pt
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies Biopsy, Biospecimen Collection, Bone Marrow Aspiration - Recurrent Chronic Lymphocytic Leukemia, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 | Terminated | Roswell Park Cancer Institute | 1 | 2024-11-26 | 2025-08-03 |
| NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma Biospecimen Collection, Computed Tomography, Heat Shock Factor 1 Pathway Inhibitor NXP800 - Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma | Phase 1 | Terminated | Mayo Clinic | 7 | 2024-05-31 | 2025-12-22 |
| Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment Biospecimen Collection, Computed Tomography, Magrolimab - Mycosis Fungoides, Recurrent Mycosis Fungoides | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 8 | 2021-04-06 | 2025-10-16 |
| Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Advanced Malignant Solid Neoplasm, Anal Carcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 79 | 2015-10-21 | 2026-01-21 |
| Proton Therapy and Bevacizumab for Primary Liver Tumors Bevacizumab, Proton Radiation Therapy - Liver Cancer, Hepatocellular Carcinoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 3 | 2007-05-01 | 2012-08-01 |
Cholangiocarcinoma (2) · Anus Neoplasms (1) · Carcinoma, Hepatocellular (1) · HIV Infections (1) · Klatskin Tumor (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Mycosis Fungoides (1) · Neoplasm Metastasis (1) · Sarcoma, Kaposi (1) · Sezary Syndrome (1)
National Cancer Institute (NCI) (2) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Roswell Park Cancer Institute (1)
United States (5) · Australia (1)
Francisco J Hernandez-ILizaliturri (1) · Lakshmi Rajdev (1) · Michael S Khodadoust (1) · Mitesh J. Borad, MD (1) · Sunil Krishnan, MD (1)
PMID 33677480, PMID 35116390, PMID 37962072, PMID 40717483
U01CA121947 (1), UM1CA121947 (1), UM1CA186717 (1)